Effect of donor–recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical–cord blood transplantation for leukemia and myelodysplastic syndrome: A retrospective analysis

The Lancet Oncology - Online First

Phase I/II study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

Blood

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia

European Journal of Haematology

Second cancer risk after chemotherapy for Hodgkins lymphoma: A collaborative british cohort study

Journal of Clinical Oncology

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

Journal of Clinical Oncology

Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia

Journal of Clinical Oncology

Favorable outcome in infants with AML after intensive first– and second–line treatment: an AML–BFM study group report

Leukemia

TOSO, the Fc{micro} Receptor, Is Highly Expressed on Chronic Lymphocytic Leukemia B Cells, Internalizes upon IgM Binding, Shuttles to the Lysosome, and Is Downregulated in Response to TLR Activation

Journal of Immunology

Imatinib Mesylate Therapy Induces Reduction in Neutrophil Gelatinase–Associated Lipocalin Serum Levels and Increase in Leptin Concentrations in Chronic Myeloid Leukemia Patients in Molecular Remission

Acta Haematologica

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia

Leukemia

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70 years old: A phase 1/2 study of the acute leukemia french association (ALFA)

American Journal of Hematology

Prognostic value of cytogenetics in adult patients with Philadelphia–negative acute lymphoblastic leukemia

Annals of Hematology

Is obesity a prognostic factor for acute myeloid leukemia outcome

Annals of Hematology

Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine–mediated inhibition of enhanced nucleotide excision repair in leukemia

International Journal of Hematology

FLAGIDA–lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts–2 and is feasible as outpatient treatment

American Journal of Hematology

BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint

Acta Haematologica

Quantitative analyses of DAPK1 methylation in AML and MDS

International Journal of Cancer

Gastrointestinal manifestations of leukemia

Journal of Gastroenterology and Hepatology

Circulating IL–17 levels during the peri–transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation

Annals of Hematology

Dysmegakaryopoiesis, a Clue for an Early Diagnosis of Familial Platelet Disorder With Propensity to Acute Myeloid Leukemia in Case of Unexplained Inherited Thrombocytopenia Associated With Normal–sized Platelets

journal of Pediatric Hematology and Oncology

Author Commentary Exclusive

Author-posted comments are available on the following article summaries